Aims The aim of this study was to find new eukaryotic sources of the l‐asparaginase (l‐ASNase), since the prokaryotic sources of the enzyme are well‐reported as causing allergic hypersensitivity reactions in a significant number of patients. This report describes screening for l‐ASNase production by filamentous fungi isolated from the Brazilian Caatinga, and the optimization of fermentation parameters to increase fungal growth and improve yield in the production of l‐ASNase. Methods and Results Thirty‐two filamentous fungi were investigated in this study. When Aspergillus terreus strain S‐18 was cultured in a proline‐enriched medium, intracellular l‐ASNase was expressed in concurrence with reduced l‐glutaminase (l‐GLUase) and protease activities. Fermentation conditions were then optimized in a 5‐l bioreactor system to produce a maximum volumetric yield of 108 U total of l‐ASNase activity. Conclusions The work reported here represents the first attempt to produce l‐ASNase by filamentous fungi isolated from Brazil and offers a promising alternative eukaryotic source for l‐ASNase production. Significance and Impact of the study In order to minimize the side effects caused by bacterial l‐ASNase, the search of eukaryotic micro‐organism for l‐ASNase was carried out in fungi. This study demonstrates the diversity of filamentous fungi isolated from the Brazilian Caatinga Biome and the importance of knowledge of the microbial metabolism to obtain high concentrations of biotechnological products.
In this work, four isolates of endophytic fungi (Alternaria alternata, Colletotrichum gloesporioides, Glomerella cingulata and Nigrospora sphaerica), deposited in the culture collection 'University Recife Mycologia' (URM) at the Universidade Federal de Pernambuco, were characterized for the genes ITS 1 and 4 (region 5.8 S) and evaluated for taxol production.
Objective: To evaluate the structural and chemical composition of plant and the antioxidant and antimicrobial activities promoted by hexanic, ethanolic and ethyl acetate fractions obtained from leaves of Conocarpus erectus. Methods: Organic fractions were characterized through UPLC-MS and GC-MS. Antioxidant potential was performed through DPPH and molybdenum phosphate techniques. Antibacterial and antifungal assays were performed in accordance with Clinical and Laboratory Standards Institute protocols. Results: The obtained biomass of Conocarpus erectus leaves showed the high presence of glucose (0.45 g/L), cellulose (28.69%), Na (55.126 μg/L) and K (31.163 μg/L). We identified seven compounds in the hexanic and ethyl acetate fractions, and eight compounds in ethanolic fraction. Moreover, phenolic compounds are prevalent in all organic fractions with values of (10.04 ± 0.24), (221.26 ± 1.84), (340.53 ± 0.84) mg/g GAE to hexanic, ethyl acetate and ethanolic fraction, respectively. Antioxidant results showed a high potential in ethyl acetate fraction (71.82 ± 6.87)% and (10.89 ± 0.05)% in DPPH and molybdenum phosphate techniques, respectively. The ethanolic fraction showed moderate bacteriostatic and bactericidal activity against Staphylococcus aureus and presented a high fungistatic potential for all Candida species tested. Conclusions: Organic fractions obtained from leaves of Conocarpus erectus present antimicrobial and antioxidant properties, and these findings contribute to scientific information for the effectiveness on use of this plant in the development of a phytotherapic compound.